The implant is about the size of a matchstick.
When Dr. Nancy DeMore wondered why her patients had to have two invasive procedures instead of one during a lumpectomy, she did something about it.
Dr. Chrystal Paulos focuses on developing novel T cell immunotherapies for patients with advanced cancer.
Dr. Peter W. Kalivas has spent two decades elucidating the biological mechanisms underlying the intrusive thoughts characteristic of addiction.
The purpose of the Office of Clinical Research (OCR) is to manage the Prospective Reimbursement Analysis (PRA) process, which includes:
• Budgeting and feasibility assessment support for industry sponsored clinical trials;
• Verification through coverage analysis of the funding sources for services associated with clinical research, i.e. third party payer versus research sponsor;
• Coverage analysis for all studies with services to be paid by third party payers, such as the patient’s insurance, to ensure allowability and billing compliance;
• Identification of and pricing support for MUSC Health services in collaboration with service providers;
• Building research records and study billing calendars in SPARCRequest to be pushed to Epic for all studies with MUSC Health billable services regardless of funding source; and
• Research billing support and monitoring to ensure that all MUSC Health charges associated with research are billed to the appropriate funding source and with the required codes and modifiers
Office of Clinical Research
Medical University of South Carolina
125 Doughty Street,
Suite 170, MSC 195
Charleston, SC 29425